· Venture Capital Tracker · investment-strategies  · 1 min read

Q1 2026 VC Hit a Record $300B Globally — But Capital Concentration Is the Real Story

Crunchbase data shows global startups raised roughly $300B in Q1 2026, with U.S.-based companies capturing ~83% and a tiny number of AI megadeals dominating the mix.

Per Crunchbase, global startup funding hit a record ~$300B in Q1 2026, with U.S.-based companies capturing ~83% (~$250B) of the total and AI dominating deal value.

The four numbers that explain Q1 2026

  1. $300B global — record.
  2. $250B U.S. — 83% of global.
  3. ~$122B OpenAI alone.
  4. $16B Waymo — largest AV round in history.

Why this matters

  • Median round dynamics diverge from headline: Even as dollars rise, deal count fell in multiple markets (Seattle, parts of Europe). Capital is concentrating into megarounds.
  • AI dominates: Nearly 89% of U.S. venture deal value went to AI-linked companies by some measures.
  • Corporate investors: Microsoft, Nvidia, Amazon, Google, Oracle, and similar corporates are responsible for a larger share of total dollars than any prior cycle.

What to watch for Q2 2026

  1. Mega-round fatigue: Will LP allocation constraints slow sovereign-size checks?
  2. Non-AI recovery: Fintech, climate, and consumer may rebound off a lower base.
  3. Regional resilience: Austin, Miami, and European hubs are outperforming Seattle and parts of the Bay Area on deal count.

Practical takeaway (founder + investor)

  1. Founders: Benchmark against your sector peer set, not headline averages.
  2. Investors: Fund pacing at record quarters often feels like FOMO; discipline beats concentration.

Sources

  1. Crunchbase Q1 2026 data: https://news.crunchbase.com/venture/record-breaking-funding-ai-global-q1-2026/
  2. SF Business Times: https://www.bizjournals.com/sanfrancisco/news/2026/04/03/venture-capital-us-q1-startups-record.html

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Back to Blog

Recommended next

Browse all research »

How Much Did AusperBio Raise? $120M Series C, No Valuation

AusperBio closed a $120 million Series C on August 27, 2026. An unnamed strategic investor led. RA Capital joined. The company cites $360 million raised since 2024. Valuation was not disclosed. AHB-137 is in Phase 3 in China and remains investigational.